Dr. Philip A. Serbin, MD

Dr. Serbin practices at Covenant Medical Group in Knoxville, Tennessee.

Dr. Serbin's NPI, 1336153311, was assigned on July 28, 2006. Dr. Serbin graduated from University of Cincinnati College of Medicine in 1985. Dr. Serbin holds Indiana license 01043057A.

Dr. Serbin's primary practice is Covenant Medical Group, at 6600 Nightingale Ln, Knoxville, TN 37909 in Knox County. The practice phone is (865) 374-5200.

Dr. Serbin's primary practice is Covenant Medical Group in Knoxville, Tennessee. Dr. Serbin is also affiliated with Fort Sanders Regional Medical Center. The medical group on file is Covenant Medical Group. Dmand AI also links Dr. Serbin to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Serbin practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Serbin's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Serbin is licensed in Indiana.

CMS data shows 986 Medicare services from Dr. Serbin across 12 procedure codes in 2024, for 342 Medicare patients. Medicare paid $73,325 for them.

CMS counts 342 Medicare patients who saw Dr. Serbin in 2024. The largest group is 65 to 74, with 141 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Serbin's median patient age at 73, with 21% women.

In 2024, Dr. Serbin wrote 1,801 Medicare Part D claims for 566 patients. 92% of them were for generic drugs. CMS names the drug for 1,649 of them, across 22 drugs with 11 or more claims each, at $63,215 in total drug cost. In 2023, CMS named 1,493 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Serbin for performance year 2024, reported individually. Dr. Serbin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Serbin as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Serbin, published from 2020 to 2024. 2022 was the busiest year, with 5. The most frequent topics are Postoperative Complications, Reoperation and Acetabulum. Dr. Serbin has published most often in Am J Sports Med. Dr. Serbin's most frequent co-authors are Senthil Sambandam, MBBS, MD, MS, Dane Kent Wukich, MD and Tyler Robert Youngman, MD.

CMS Open Payments shows 5 general payments to Dr. Serbin from 5 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 81% of the total. Organogenesis Inc. paid the most, $100.

Dr. Serbin graduated from University of Cincinnati College of Medicine in 1985.